advertisement
11.5.2 Topical (14)
Showing records 1 to 14
Display all abstracts in classification 11.5.2 Topical
Search within classification 11.5.2 Topical15386 Optic nerve oxygen tension in pigs and the effect of carbonic anhydrase inhibitors
Stefansson E; Jensen PK; Eysteinsson T; Bang K; Kiilgaard JF; Dollerup J; Scherfig E; la Cour M
Investigative Ophthalmology and Visual Science 1999; 40: 2756-2761
15426 Ocular pulse amplitude, intraocular pressure and beta-blocker/carbonic anhydrase combination therapy
Schmidt KG; Von Rückmann A; Becker R; Pillunat LE
Klinische Monatsblätter für Augenheilkunde 1999; 215: 361-366
15477 Efficacy and tolerance of dorzolamide in patients with secondary inflammatory glaucoma associated with juvenile chronic arthritis: a 6-month follow-up study
Assi A; Watts P
Annals of Ophthalmology - Glaucoma 1999; 31: 329-332
15500 Comparison of dorzolamide and pilocarpine as adjunctive therapy in patients with open-angle glaucoma and ocular hypertension
Hartenbaum D; Maloney S; Vaccarelli L; Liss C; Wilson H; Gormley GJ
Clinical Therapeutics 1999; 21: 1533-1538
15501 The dorzolamide/timolol combination versus timolol plus pilocarpine: patient preference and impact on daily life
Sverrisson T; Gross R; Pearson J; Rusk C; Adamsons I; United States Patient Preference Study Group; International Patient Preference Study Group
Journal of Glaucoma 1999; 8: 315-324
15525 Effect of dorzolamide and latanoprost on intraocular pressure after small incision cataract surgery
Rainer G; Menapace R; Schmetterer K; Findl O; Georgopoulos M; Vass C
Journal of Cataract and Refractive Surgery 1999; 25: 1624-1629
15528 A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol and dorzolamide
Boyle JE; Ghosh K; Gieser DK; Adamsons IA
Ophthalmology 1999; 106: 10-16
15529 A randomized trial in patients inadequately controlled with timolol alone comparing the dorzolamide-timolol combination to monotherapy with timolol or dorzolamide
Clineschmidt CM; Williams RD; Snyder E; Adamsons IA
Ophthalmology 1999; 106: 17-24
15530 Effect of brinzolamide and dorzolamide on aqueous humor flow in human eyes
Ingram CJ; Brubaker RF
American Journal of Ophthalmology 1999; 128: 292-296
15531 Carbonic anhydrase inhibitors: synthesis of water-soluble, aminoacyl/dipeptidyl sulfonamides possessing long-lasting intraocular pressure-lowering properties via the topical route
Scozzafava A; Briganti F; Mincione G; Menabuoni L; Mincione F; Supuran CT
Journal of Medicinal Chemistry 1999; 42: 3690-3700
15532 The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components
Strohmaier K; Snyder E; DuBiner H; Adamsons IA
Ophthalmology 1999; 106: 1-9
15533 Pharmacological and ocular hypotensive properties of topical carbonic anhydrase inhibitors
Sugrue MF
Progress in Retinal and Eye Research 2000; 19: 87-112
15534 Carbonic anhydrase inhibitors - Part 70. Synthesis and ocular pharmacology of a new class of water-soluble, topically effective intraocular pressure lowering agents derived from nicotinic acid and aromatic/heterocyclic sulfonamides
Supuran CT; Scozzafava A; Menabuoni L; Mincione F; Briganti F; Mincione G
European Journal of Medicinal Chemistry 1999; 34: 799-808
15535 Biochemical and ultrastructural changes in rabbit sclera after treatment with 7-methylxanthine, theobromine, acetazolamide, or L-ornithine
Trier K; Olsen EB; Kobayashi T; Ribel-Madsen SM
British Journal of Ophthalmology 1999; 83: 1370-1375